Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/06/2003US20030044981 Pseudotyped lentiviral vectors and uses thereof
03/06/2003US20030044980 Methods for low background cloning of DNA using long oligonucleotides
03/06/2003US20030044979 Nucleotide sequences for use in the treatment of inflammation, cancer and immunological disorders
03/06/2003US20030044974 Method for collecting cells in M phase or G1 phase and method for nuclear transplantation using the cells
03/06/2003US20030044973 Mammalian adrenocorticotropic hormone receptors and uses
03/06/2003US20030044972 Maize chloroplast protein synthesis elongation factors and methods of use for same
03/06/2003US20030044968 Capillary array-based sample screening
03/06/2003US20030044963 Generation of adenoviral vectors; provide cell suspension, mix with adenoviral vector, transform cells, propagate recover adenoviral virons
03/06/2003US20030044961 Compositions for transferring active compounds in a cell-specific manner
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044958 Nucleotide sequences coding polypeptide for use in monitoring and treating inflammatory disorders
03/06/2003US20030044957 Zinc finger proteins for DNA binding and gene regulation in plants
03/06/2003US20030044956 Nucleotide sequences coding glucanase for use in detergents and textile processing
03/06/2003US20030044955 Expression vector for use as tool in the transfer and expression of heterologous polypeptides in fungi
03/06/2003US20030044953 Novel telomerase
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044948 56919, A novel human acyltransferase and uses thereof
03/06/2003US20030044947 Nucleotide sequences coding polypeptide for use in controlling methanol metabolism in yeast
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044941 Genetically engineering preferential nucleotide sequences; obtain nucleotide sequences, incubate with probe, incubate with ribonuclease, recover adjusted nucleotide sequences
03/06/2003US20030044940 Method for increasing gene copy number in a host cell and resulting host cell
03/06/2003US20030044939 Process and materials for production of glucosamine
03/06/2003US20030044938 Method to produce novel polyketides
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044936 Peptide repeat immunogens
03/06/2003US20030044933 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative, cardiovascular, nervous system, bone, inflammatory, endothelial, liver, viral, pain and metabolic disorders
03/06/2003US20030044912 KCNQ potassium channels and methods of modulating same
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044909 Modulator of melatonin binding for use in the treatment of circadian rythm disorders
03/06/2003US20030044906 Nucleic acids, proteins, and processes for producing proteins such as fusion proteins for the secretion of a protein of interest into bacterial supernatants
03/06/2003US20030044901 Polypeptide for use in animal models associated with human therapeutics
03/06/2003US20030044900 Generation of human kinesin protein; obtain bacterial cell, transform with expression vector coding kinesin protein, express vector, isolate and recover protein
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044896 Generation of enzyme sensitie polypeptde; obtain mutant yeast cell, transform with vector coding enzyme sensitive polypeptide, express vector and polypeptide, isolate polypeptide
03/06/2003US20030044895 Nucleotide sequences coding polypeptide for use in t he treatment of tumors, respiratory and liver disorders
03/06/2003US20030044894 Sterilizing of transformed microorganism; generation nutrient broth, inoculate with microorganism, heat, express vector, recover heat resistant protein
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044892 Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestine
03/06/2003US20030044891 Nucleotide sequences coding mutant protein for use in generation of vaccine which prevents bordetella infections
03/06/2003US20030044889 Human HAC3
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044887 Neurogenin
03/06/2003US20030044866 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays
03/06/2003US20030044863 Diagnosing cancer in humans; obtain tissue sample, detect invasive complexes associated tissus, evaluate for cancer
03/06/2003US20030044859 Reagents and methods useful for detecting diseases of the breast
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044838 Generation of peptides which bind bacterial spores; btain phage, incubate with spore, centrifuge, wash, elute, amplify eluted phage, purifying clones, amplify clones, extract nucleotide sequences incubate with peptide, monitor binding
03/06/2003US20030044834 GDU, a novel signalling protein
03/06/2003US20030044831 Antibody for use in the generation and protection of preferential nucleotide sequences
03/06/2003US20030044830 Method of reducing background in florescence detection
03/06/2003US20030044828 Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis
03/06/2003US20030044822 Colorimetric in situ hybridization detection methods
03/06/2003US20030044820 Rapid and enzymeless cloning of nucleic acid fragments
03/06/2003US20030044819 Triple-stranded DNA, method of forming the same and southern hybridization
03/06/2003US20030044818 Generation of nucleic acid ligand to tissue or fluid; obtain tissue, incubate with nucleotide sequences primer, amplify, monitor binding affinity
03/06/2003US20030044817 Kits for use in the amplification of nucleotide sequences
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044810 Methods, compositions, and kits relating to cardiovascular disease
03/06/2003US20030044809 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
03/06/2003US20030044807 Rhodococcus cloning and expression vectors
03/06/2003US20030044806 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044791 Oligonucleotide composition for use in nucleotide sequence analysis
03/06/2003US20030044788 Detection of modulators or kinase activity; obtain sample containing kinase, incubate with modulators, monitor adjustment in enzyme activity, adjustment in activity indicates modulator
03/06/2003US20030044787 Methods and compositions for interaction trap assays
03/06/2003US20030044786 Reducing impurities in nucleotide sequence amplification; obtain nucleotide sequences, incubate with primer, expose to polymerase, amplify, recover nucleotide sequences
03/06/2003US20030044783 Human genes and gene expression products
03/06/2003US20030044781 Sequencing target nucleic acid; prepare reaction mixture, incubate with nucleotides and primers, amplify, determine sequence of nucleic acid
03/06/2003US20030044780 Detection of preferential nucleotide sequences in sample; obtain nucleotide sequences, incubate with primers, amplify, detect target sequences
03/06/2003US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide
03/06/2003US20030044768 PD-1, a receptor for B7-4, and uses therefor
03/06/2003US20030044767 Screening modulators of cellular activity; obtain cells, transform with nucleotide sequence, express nucleotide sequences, translate, monitor cell for adjustment in cellular activity
03/06/2003US20030044450 Oral vaccines
03/06/2003US20030044429 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer
03/06/2003US20030044423 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype
03/06/2003US20030044422 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use
03/06/2003US20030044421 Adenoviral vaccines when administered alone or in combined modality regime offer prophylactic advantage to previously uninfected individuals and/or provide therapeutic effect by reducing viral load levels within infected individual
03/06/2003US20030044420 Polypeptide self-antigen useful in tumor-specific vaccine mimics epitopes of antigen uniquely expressed by cells of the tumor; polypeptide is preferably produced in plant transformed or transfected with nucleic acid encoding the polypeptide
03/06/2003US20030044419 Use of reagents derived from nucleic acid and amino acid sequences of Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines
03/06/2003US20030044417 Self antigen vaccines for treating B cell lymphomas and other cancers
03/06/2003US20030044409 Complexing to epitope; cancer immunotherapy
03/06/2003US20030044408 Surface modification for improving biocompatibility
03/06/2003US20030044407 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
03/06/2003US20030044405 Sustained release; drug delivery; tissue adhesive
03/06/2003US20030044403 Anti-infective therapy
03/06/2003US20030044401 Anticancer agents; prevent drug resistance
03/06/2003US20030044392 Gene therapy; prevent transformation of cells
03/06/2003US20030044389 Cell differentiation; labeling
03/06/2003US20030044388 Methods for detecting DNA originating from different individuals
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030044385 Antitumor, anticancer agents
03/06/2003US20030044383 Tissue specific adenoviral vectors
03/06/2003US20030043176 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030042203 Complex of metal oxide and alcohol
03/06/2003CA2496180A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003CA2459697A1 Apparatus and method for electroporation of biological samples
03/06/2003CA2459183A1 Amplified oncogenes and their involvement in cancer
03/06/2003CA2459141A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458849A1 Obesity related genes expressed at least in the hypothalamus, liver or pancreas
1 ... 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 ... 4023